XASXCOH
Market cap11bUSD
Dec 20, Last price
289.08AUD
1D
-0.70%
1Q
2.33%
Jan 2017
135.89%
Name
Cochlear Ltd
Chart & Performance
Profile
Cochlear Limited provides implantable hearing solutions for adults and children worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
IPO date
Dec 04, 1995
Employees
4,800
Domiciled in
AU
Incorporated in
AU
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 2,258,200 15.47% | 1,955,700 19.17% | 1,641,100 9.90% | |||||||
Cost of revenue | 1,736,700 | 1,543,300 | 1,279,400 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 521,500 | 412,400 | 361,700 | |||||||
NOPBT Margin | 23.09% | 21.09% | 22.04% | |||||||
Operating Taxes | 128,000 | 96,000 | 104,700 | |||||||
Tax Rate | 24.54% | 23.28% | 28.95% | |||||||
NOPAT | 393,500 | 316,400 | 257,000 | |||||||
Net income | 356,800 18.70% | 300,600 3.98% | 289,100 -11.45% | |||||||
Dividends | (245,700) | (197,400) | (194,000) | |||||||
Dividend yield | 1.13% | 1.31% | 1.48% | |||||||
Proceeds from repurchase of equity | (42,900) | (40,300) | (2,200) | |||||||
BB yield | 0.20% | 0.27% | 0.02% | |||||||
Debt | ||||||||||
Debt current | 41,600 | 39,200 | 78,700 | |||||||
Long-term debt | 445,800 | 325,200 | 350,400 | |||||||
Deferred revenue | 8,600 | 9,800 | 7,800 | |||||||
Other long-term liabilities | 43,500 | 51,200 | 46,400 | |||||||
Net debt | (109,600) | (381,700) | (390,500) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 388,800 | 362,400 | 376,500 | |||||||
CAPEX | (62,400) | (95,900) | (77,200) | |||||||
Cash from investing activities | (105,700) | (125,700) | (138,900) | |||||||
Cash from financing activities | (323,800) | (310,400) | (220,700) | |||||||
FCF | 242,000 | 272,500 | 247,300 | |||||||
Balance | ||||||||||
Cash | 513,600 | 555,500 | 629,300 | |||||||
Long term investments | 83,400 | 190,600 | 190,300 | |||||||
Excess cash | 484,090 | 648,315 | 737,545 | |||||||
Stockholders' equity | 1,840,500 | 1,748,800 | 1,685,700 | |||||||
Invested Capital | 1,652,210 | 1,363,285 | 1,241,055 | |||||||
ROIC | 26.10% | 24.30% | 20.83% | |||||||
ROCE | 24.20% | 20.32% | 18.08% | |||||||
EV | ||||||||||
Common stock shares outstanding | 65,709 | 65,897 | 65,771 | |||||||
Price | 332.15 45.00% | 229.07 15.28% | 198.70 -21.05% | |||||||
Market cap | 21,825,252 44.59% | 15,094,992 15.51% | 13,068,627 -21.00% | |||||||
EV | 21,715,652 | 14,713,292 | 12,678,127 | |||||||
EBITDA | 521,500 | 493,300 | 434,700 | |||||||
EV/EBITDA | 41.64 | 29.83 | 29.17 | |||||||
Interest | 9,200 | 9,400 | 8,600 | |||||||
Interest/NOPBT | 1.76% | 2.28% | 2.38% |